Evidence map›Paper›PMID 23228508›Full record

ReviewTrends in cell biology2013

PolyQ disease: misfiring of a developmental cell death program?

Elyse S Blum, Andrew R Schwendeman, Shai Shaham

Open access · greenAbstract readReview
In one paragraph

Review in Trends in cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Non-apoptotic cell death in animal development.Cell death and differentiation · 2017
    Review
  15. Cross-β Polymerization of Low Complexity Sequence Domains.Cold Spring Harbor perspectives in biology · 2017
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elyse S BlumLaboratory of Developmental Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.
Andrew R Schwendeman
Shai Shaham
Rockefeller University · US

Funding

Developmental control of apoptosis in C.elegansR01HD042680 · NICHD · ROCKEFELLER UNIVERSITY · PI SHAHAM, SHAI · 2002 to 2011
$3.0M
Control of nonapoptotic C. elegans cell death similar to neurodegenerationR01NS081490 · NINDS · ROCKEFELLER UNIVERSITY · PI SHAHAM, SHAI · 2012 to 2017
$2.2M
NICHD NIH HHS R01 HD042680NINDS NIH HHS NS081490NINDS NIH HHS R01 NS081490
6 · The paper itself

Abstract

Polyglutamine (polyQ) repeat diseases are neurodegenerative ailments elicited by glutamine-encoding CAG nucleotide expansions within endogenous human genes. Despite efforts to understand the basis of these diseases, the precise mechanism of cell death remains stubbornly unclear. Much of the data seem to be consistent with a model in which toxicity is an inherent property of the polyQ repeat, whereas host protein sequences surrounding the polyQ expansion modulate severity, age of onset, and cell specificity. Recently, a gene, pqn-41, encoding a glutamine-rich protein, was found to promote normally occurring non-apoptotic cell death in Caenorhabditis elegans. Here we review evidence for toxic and modulatory roles for polyQ repeats and their host proteins, respectively, and suggest similarities with pqn-41 function. We explore the hypothesis that toxicity mediated by glutamine-rich motifs may be important not only in pathology, but also in normal development.

Indexed as

AgingAnimalsCell DeathGrowth and DevelopmentHumansNeurodegenerative DiseasesPeptidesTrinucleotide Repeat ExpansionPeptidespolyglutamine

Identifiers

PMID23228508
PMCPMC3610856
OpenAlexW2037449788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.